Status:
COMPLETED
Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients
Lead Sponsor:
Assiut University
Conditions:
Psoriasis
Eligibility:
All Genders
18-75 years
Brief Summary
Aims of the study: 1. Measurement of serum level of Mac 2 binding protein among patients with psoriasis, psoriatic arthritis and subclinical psoriatic arthritis compared with healthy individuals. 2. ...
Detailed Description
Psoriasis is a quite common chronic, inflammatory immune-mediated skin disease affecting about 2% of the population . Also psoriasis is a strong risk factor for the development of several comorbiditie...
Eligibility Criteria
Inclusion
- cutaneous psoriasis Psoriatic arthritis Subclunical psoriatic arthritis
Exclusion
- any history of liver diseases non-alcoholic fatty liver, viral hepatitis, human immunodeficiency virus (HIV), autoimmune rheumatic disease other than psoriasis and PSA malignancy.
Key Trial Info
Start Date :
October 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04435730
Start Date
October 15 2020
End Date
June 30 2023
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sylvia
Asyut, Egypt